Skip to main content

Our new intranet / wiki is online!

A new wiki/ intranet for the Cluster of Excellence ImmunoSensation is now available for our member:

https://confluence.team.uni-bonn.de/x/n4hWAQ

Thereby we use Confluence form the University of Bonn, where some Uni institutions (like the HRZ or Human Resources Development) with their areas can already be found.

In our new wiki / intranet information about our funding opportunities; Software and Hardware within the Cluster or important documentes for e.g. travel expenses can be found.

Access to Confluence is available to all employees with an Uni-ID.The access to the area for the cluster is limited, that means you will not see the area in the overview at the beginning.Confluence can be reached via eduroam/bonnet network or by using the Uni-VPN client.

Only after you have registered in the following form and we have activated your account you will have access to our area.

Registration: https://www.umfrageonline.com/s/d070df5

In the attachment you will find an FAQ with all relevant links and details about the requirements for usage as well as further information (for example contents of the area).

If you have any questions or feedback regarding our Confluence area, please feel free to contact us.We are happy if the new wiki is used a lot and we can encourage a good exchange!

Related news

News Icon

News categories: Publication

Twin Lancet Publications Highlight Promising New Approach for Lupus Treatment

A team of international researchers, including ImmunoSensation³ member Prof. Jörg Wenzel, reports promising phase 2 results for enpatoran, a first-in-class oral TLR7/8 inhibitor, in patients with cutaneous and systemic lupus erythematosus (CLE/SLE). In the WILLOW trial, enpatoran significantly improved skin disease activity in a dose-dependent manner and showed favourable safety outcomes. In systemic SLE, treatment also reduced global disease activity and rapidly suppressed the type I interferon gene signature. The twin studies were published in The Lancet and The Lancet Rheumatology.
View entry
Wissenschaftler

News categories: Publication

Driver of inflammation after mild head injury

Mild traumatic brain injuries can lead to persistent memory problems and an increased risk of dementia. Yet, effective therapies to counteract these long-term consequences are still lacking. Dr. Dr. Sergio Castro-Gomez, Early Career Research Group Leader at the Institute of Physiology II of the University Hospital Bonn has discovered together with colleagues that the ASC protein. The research team hopes to identify new targets for future therapeutic strategies. The study, published in the Journal of Clinical Investigation, lays the foundation for upcoming clinical trials.
View entry
Children in the lab at "Girls' and Boys' Day 2026"

News categories: Outreach

Girls' & Boys' Day at ImmunoSensation³

The annual "Girls' & Boys' Day" (former "Girls' day") sets out to introduce children and young addults to careers their respective gender is still underrepresented in. To celebrate this special day and offer insights into the work of a biomedical researcher, we welcomed students from all over Germany to our laboratories. Besides hands-on science, career options and perspectives in research were discussed.
View entry

Back to the news overview